Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Ward

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2022
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanomaPingyan Cheng, Xianghong Chen, Robert Dalton, et al.
Immunity|August 1, 2025
Innate-like memory T cells rapidly emerge in humans after gene therapy for SCID-X1Anoop Babu Vasandan, Hossam A Abdelsamed, Shannon K Boi, et al.
The Journal of Investigative Dermatology|June 24, 2022
Association of S100A8/A9 with Lipid-Rich Necrotic Core and Treatment with Biologic Therapy in Patients with Psoriasis: Results from an Observational Cohort StudyAlexander R Berg, Christin G Hong, Maryia Svirydava, et al.
Science (New York, N.Y.)|October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapyTae Gun Kang, Xin Lan, Tian Mi, et al.
Iscience|April 18, 2023
CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignanciesThuLe Trinh, William A Adams, Alexandra Calescibetta, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2022
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanomaPingyan Cheng, Xianghong Chen, Robert Dalton, et al.
Immunity|August 1, 2025
Innate-like memory T cells rapidly emerge in humans after gene therapy for SCID-X1Anoop Babu Vasandan, Hossam A Abdelsamed, Shannon K Boi, et al.
The Journal of Investigative Dermatology|June 24, 2022
Association of S100A8/A9 with Lipid-Rich Necrotic Core and Treatment with Biologic Therapy in Patients with Psoriasis: Results from an Observational Cohort StudyAlexander R Berg, Christin G Hong, Maryia Svirydava, et al.
Science (New York, N.Y.)|October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapyTae Gun Kang, Xin Lan, Tian Mi, et al.
Iscience|April 18, 2023
CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignanciesThuLe Trinh, William A Adams, Alexandra Calescibetta, et al.
Pageof 2